Evidence map›Paper›PMID 27297128›Full record

ReviewAsian journal of andrology

46 XX karyotype during male fertility evaluation; case series and literature review.

Ahmad Majzoub, Mohamed Arafa, Christopher Starks, Haitham Elbardisi, Sami Al Said, Edmund Sabanegh

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Asian journal of andrology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. JCEM case reports · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. 46,XX male disorder of sexual development.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2020
    Article
  15. Male patient 46,XX SRY-negative and unambiguous genitalia: A case reportBiomedica : revista del Instituto Nacional de Salud · 2019
    Article
  16. Sexual dysfunction and male infertility.Nature reviews. Urology · 2018
    Review
  17. Article
  18. Ten cases with 46,XX testicular disorder of sex development: single center experience.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Ahmad MajzoubCleveland Clinic Foundation, Department of Urology, Cleveland, Ohio, USA.
Mohamed ArafaCairo University, Department of Andrology, Giza, Egypt.
Christopher StarksReston Hospital, Department of Urology, Virginia, USA.
Haitham ElbardisiHamad Medical Corporation, Department of Urology, Qatar.
Sami Al SaidHamad Medical Corporation, Department of Urology, Qatar.
Edmund SabaneghCleveland Clinic Foundation, Department of Urology, Cleveland, Ohio, USA.
Cleveland Clinic · USHamad Medical Corporation · QACairo University · EGVirginia Hospital Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Forty-six XX disorder of sex development is an uncommon medical condition observed at times during the evaluation of a man's fertility. The following is a case series and literature review of phenotypically normal men diagnosed with this karyotype. Our goal is to comprehend the patients' clinical presentation as well as their laboratory results aiming to explore options available for their management. A formal literature review through PubMed and MEDLINE databases was performed using "46 XX man" as a word search. A total of 55 patients, including those conveyed in this article were diagnosed with a 46 XX karyotype during their fertility evaluation. The patients' mean age ± s.d. was 34 ± 10 years and their mean height ± s.d. was 166 ± 6.5 cm. Overall, they presented with hypergonadotropic hypogonadism. Sexual dysfunction, reduced hair distribution, and gynecomastia were reported in 20% (4/20), 25.8% (8/31), and 42% (13/31) of the patients, respectively. The SRY gene was detected in 36 (83.7%) and was absent in the remaining seven (16.3%) patients. We found that a multidisciplinary approach to management is preferred in 46 XX patients. Screening for remnants of the mullerian ducts and for malignant transformation in dysgenetic gonads is imperative. Hypogonadism should be addressed, while fertility options are in vitro fertilization with donor sperm or adoption.

Indexed as

46, XX Disorders of Sex DevelopmentAdultAzoospermiaFollicle Stimulating HormoneHumansHypogonadismInfertility, MaleIn Situ Hybridization, FluorescenceKaryotypeLuteinizing HormoneMaleTestosteroneFollicle Stimulating HormoneLuteinizing HormoneTestosterone

Identifiers

PMID27297128
PMCPMC5312213
OpenAlexW2344726973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.